PD-1 and PD-L1 engagement dampens T effector cells function, which leads to impairment of effective immune response against the tumor; thus, overexpression of PD-L1 has been correlated with poor prognosis in NSCLC [142]. This evidence concerns the gene CD274 and neoplasm.